
Endo divests Grupo Farmaceutico Somar to PE firm Advent International
Executive Summary
Endo International PLC divested Grupo Farmaceutico Somar to private equity investor Advent International for $124mm in cash.
Deal Industry
- Pharmaceuticals
-
Pharmaceuticals
- Generic Drugs
- OTC, Consumer
Deal Status
- Final
Deal Type
-
Acquisition
- Buy-out
- Full Acquisition
- Payment Includes Cash for Equity
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com